BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Site Contracts: a Global Assessment From KMR Group


4/11/2012 8:38:35 AM

CHICAGO, Illinois, April 10, 2012 KMR GROUP, a firm specializing on biopharmaceutical R&D performance, is pleased to announce that its current Site Contracts Study will begin this month. It is global in scope. The cycle time analysis assesses the study start-up process from the site contract and regulatory documents perspective.

The survey not only shows each company how their site contracting process compares with other major companies in the industry, but also provides context around more qualitative site contracting practices such as use of master agreements, payment strategies, timing and terms.

Site contract performance is being analyzed from a number of perspectives including the type of site (independent, institution), study phase, therapy area and geography. As this is the third time KMR is conducting this study, the results will also include trends over time.

“Faster contracting times translate into faster study start-up, the most time consuming portion of a clinical trial. By providing companies with reliable, detailed site contract benchmarks as well as an assessment of their own performance, the study will provide each company with information they can directly employ to enhance their site contract strategies and performance improvement efforts,” commented Linda Martin, Principal of KMR Group.

For further information contact:

Lyndsey McKay, Marketing Manager Tel: +1 (312) 795-0400 Email: lmckay@kmrgroup.com

About KMR

KMR has been working exclusively in the biopharmaceutical R&D industry since the early 1990s. KMR is a leader in benchmarking, analytics and performance management. With an exclusive focus on biopharmaceutical R&D and unrivaled commitment to data quality, KMR provides industry with the experience and knowledge to produce clear and uncompromising results in the form of reports, tools and presentations. We use our extensive, unparalleled datasets and experience within the industry to add value to the most pressing business questions. Please visit our website at http://kmrgroup.com

KMR Group

150 North Wacker Drive, Suite 1070 Chicago, Illinois 60606 USA

312-795-0400

Fax 312-795-0491

www.kmrgroup.com

Copyright © KMR Group 2012 All rights reserved.



Read at BioSpace.com

KMR Group
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES